Search

Tandem Diabetes Care Inc

Geschlossen

BrancheGesundheitswesen

19.79 -2.37

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

19.79

Max

20.34

Schlüsselkennzahlen

By Trading Economics

Einkommen

-775K

-21M

Verkäufe

7.3M

255M

EPS

-0.31

Gewinnspanne

-8.316

Angestellte

2,500

EBITDA

4.5M

-9.2M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+32.96% upside

Dividenden

By Acuity

Nächstes Ergebnis

5. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

153M

1.5B

Vorheriger Eröffnungskurs

22.16

Vorheriger Schlusskurs

19.79

Nachrichtenstimmung

By Acuity

50%

50%

143 / 339 Ranking in Healthcare

Tandem Diabetes Care Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Sept. 2026, 20:08 UTC

Tandem Diabetes Care Inc shares are lower, continuing a five-session decline amid broader selling pressure following a strong jobs report.

1. Sept. 2026, 20:02 UTC

Tandem Diabetes Care is trading lower amid broader economic concerns, including rising oil prices and inflation worries impacting interest rate expectations.

31. Aug. 2026, 20:03 UTC

News

Tandem Diabetes Care Inc shares are higher during Monday's session, rebounding sharply after an initial dip amid broader market volatility from recent economic remarks.

27. Aug. 2026, 20:07 UTC

Tandem Diabetes Care Inc shares are higher today, reflecting a modest overall market gain. No specific news was identified to explain the movement.

25. Aug. 2026, 20:07 UTC

Tandem Diabetes Care shares are lower today, continuing a trend of five consecutive daily declines. Earlier, the stock reached a session high before pulling back.

24. Aug. 2026, 19:36 UTC

News

Tandem Diabetes Care shares are lower today, following a downward trend since Friday. Analysts maintain a "Hold" consensus, with targets ranging from $18 to $40.

21. Aug. 2026, 19:46 UTC

Tandem Diabetes Care Inc. shares are roughly flat today, showing some volatility with a high of 2.13% and a low of -2.80%.

20. Aug. 2026, 20:02 UTC

Tandem Diabetes Care Inc shares are lower amid broader market pressures following Walmart Inc's disappointing earnings report, raising concerns about consumer spending.

19. Aug. 2026, 19:46 UTC

Tandem Diabetes Care Inc. shares are higher, reflecting routine performance amid a broader rebound in stock prices linked to declining bond yields.

18. Aug. 2026, 20:01 UTC

Tandem Diabetes Care is trading higher today, reflecting strong intraday performance despite recent lower finishes. The stock remains above its 20-day moving average.

17. Aug. 2026, 19:46 UTC

News

Tandem Diabetes Care shares are lower as investor caution follows its Q2 earnings report, despite meeting revenue and profit expectations.

14. Aug. 2026, 20:06 UTC

Tandem Diabetes Care shares are lower today amid economic concerns following a disappointing U.S. retail sales report for July. The stock remains above its 20-day moving average.

13. Aug. 2026, 19:16 UTC

Tandem Diabetes Care shares are trading lower today, despite broader market support and an early high. Initial jobless claims rose, indicating potential labor market softening.

12. Aug. 2026, 19:41 UTC

News

Tandem Diabetes Care reported a narrower second-quarter loss of 31 cents per share, with revenues of $254.6 million, as shares rise since Tuesday.

11. Aug. 2026, 19:46 UTC

News

Tandem Diabetes Care reported improved second-quarter results, including a narrower loss and increased revenue, supporting shares' advance during Tuesday's session.

10. Aug. 2026, 19:36 UTC

News

Tandem Diabetes Care reported second-quarter revenue of $254.6 million and reaffirmed its full-year guidance of $1.08 billion, supporting a higher share price today.

7. Aug. 2026, 20:02 UTC

News

Tandem Diabetes Care shares rose after Q2 sales of $254.6 million and adjusted EBITDA of $6.4 million exceeded forecasts, despite RBC lowering its price target to $26.

6. Aug. 2026, 23:02 UTC

News

Tandem Diabetes Care reported Q2 sales of $254.6 million and reaffirmed revenue guidance, with shares trading higher in after-market hours.

5. Aug. 2026, 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4. Aug. 2026, 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31. Juli 2026, 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

30. Juli 2026, 17:11 UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

29. Juli 2026, 18:15 UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

27. Juli 2026, 19:21 UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

24. Juli 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21. Juli 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20. Juli 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Peer-Vergleich

Kursveränderung

Tandem Diabetes Care Inc Prognose

Kursziel

By TipRanks

32.96% Vorteil

12-Monats-Prognose

Durchschnitt 26.46 USD  32.96%

Hoch 50 USD

Tief 15.5 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Tandem Diabetes Care Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

15 ratings

8

Buy

7

Halten

0

Sell

Stimmung

By Acuity

143 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
help-icon Live chat